| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |